Analysis of Local Control Outcomes and Clinical Prognostic Factors in Localized Pelvic Ewing Sarcoma Patients Treated With Radiation Therapy: A Report From the Children's Oncology Group

To identify potential clinical prognostic factors associated with a higher risk of local recurrence in patients with localized pelvic Ewing sarcoma treated with radiation therapy. Data for 101 patients treated with definitive radiation therapy (RT) or both surgery and radiation (S + RT) to primary p...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of radiation oncology, biology, physics Vol. 115; no. 2; pp. 337 - 346
Main Authors Ahmed, Safia K., Witten, Brent G., Harmsen, William S., Rose, Peter S., Krailo, Mark, Marcus, Karen J., Randall, R. Lor, DuBois, Steven G., Janeway, Katherine A, Womer, Richard B., Grier, Holcombe E., Gorlick, Richard G., Laack, Nadia N.I.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.02.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To identify potential clinical prognostic factors associated with a higher risk of local recurrence in patients with localized pelvic Ewing sarcoma treated with radiation therapy. Data for 101 patients treated with definitive radiation therapy (RT) or both surgery and radiation (S + RT) to primary pelvic tumors on INT-0091, INT-0154, and AEWS0031 were analyzed. Imaging data for patients who did not receive radiation were not available for central review; therefore, patients with surgery alone were not included. Cumulative incidence rates for local failure at 5 years from time of local control were calculated accounting for competing risks. The most common pelvic subsite was sacrum (44.6%). RT was used in 68% of patients and S + RT in 32%. The local failure rate was 25.0% for RT and 6.3% for S + RT (P = .046). There was no statistically significant difference in local control modality by tumor characteristics. Tumors originating in the ischiopubic-acetabulum region were associated with the highest local failure incidence, 37.5% (P = .02, vs sacrum and iliac/buttock tumors), particularly those treated with RT (50.0%, P = .06). A higher incidence of local failure was seen with each additional 100 mL of tumor at diagnosis (P = .04). Multivariable analysis demonstrated RT alone (hazard ratio [HR], 5.1; P = .04), tumor subsite (particularly ischiopubic-acetabulum tumors; HR 4.6; P = .02), and increasing volume per 100 mL (HR, 1.2; P = .01) were associated with a higher incidence of local recurrence. Combination surgery and RT is associated with improved local control in patients with pelvic Ewing sarcoma compared with definitive RT. Tumors involving the ischiopubic-acetabulum region and increasing tumor volume at diagnosis are associated with inferior local control. Tumor characteristics did not correlate with choice of local therapy modality suggesting an opportunity to develop best local therapy practices guidelines for future studies based on tumor features.
AbstractList To identify potential clinical prognostic factors associated with a higher risk of local recurrence in patients with localized pelvic Ewing sarcoma treated with radiation therapy. Data for 101 patients treated with definitive radiation therapy (RT) or both surgery and radiation (S + RT) to primary pelvic tumors on INT-0091, INT-0154, and AEWS0031 were analyzed. Imaging data for patients who did not receive radiation were not available for central review; therefore, patients with surgery alone were not included. Cumulative incidence rates for local failure at 5 years from time of local control were calculated accounting for competing risks. The most common pelvic subsite was sacrum (44.6%). RT was used in 68% of patients and S + RT in 32%. The local failure rate was 25.0% for RT and 6.3% for S + RT (P = .046). There was no statistically significant difference in local control modality by tumor characteristics. Tumors originating in the ischiopubic-acetabulum region were associated with the highest local failure incidence, 37.5% (P = .02, vs sacrum and iliac/buttock tumors), particularly those treated with RT (50.0%, P = .06). A higher incidence of local failure was seen with each additional 100 mL of tumor at diagnosis (P = .04). Multivariable analysis demonstrated RT alone (hazard ratio [HR], 5.1; P = .04), tumor subsite (particularly ischiopubic-acetabulum tumors; HR 4.6; P = .02), and increasing volume per 100 mL (HR, 1.2; P = .01) were associated with a higher incidence of local recurrence. Combination surgery and RT is associated with improved local control in patients with pelvic Ewing sarcoma compared with definitive RT. Tumors involving the ischiopubic-acetabulum region and increasing tumor volume at diagnosis are associated with inferior local control. Tumor characteristics did not correlate with choice of local therapy modality suggesting an opportunity to develop best local therapy practices guidelines for future studies based on tumor features.
PURPOSETo identify potential clinical prognostic factors associated with a higher risk of local recurrence in patients with localized pelvic Ewing sarcoma treated with radiation therapy.METHODS AND MATERIALSData for 101 patients treated with definitive radiation therapy (RT) or both surgery and radiation (S + RT) to primary pelvic tumors on INT-0091, INT-0154, and AEWS0031 were analyzed. Imaging data for patients who did not receive radiation were not available for central review; therefore, patients with surgery alone were not included. Cumulative incidence rates for local failure at 5 years from time of local control were calculated accounting for competing risks.RESULTSThe most common pelvic subsite was sacrum (44.6%). RT was used in 68% of patients and S + RT in 32%. The local failure rate was 25.0% for RT and 6.3% for S + RT (P = .046). There was no statistically significant difference in local control modality by tumor characteristics. Tumors originating in the ischiopubic-acetabulum region were associated with the highest local failure incidence, 37.5% (P = .02, vs sacrum and iliac/buttock tumors), particularly those treated with RT (50.0%, P = .06). A higher incidence of local failure was seen with each additional 100 mL of tumor at diagnosis (P = .04). Multivariable analysis demonstrated RT alone (hazard ratio [HR], 5.1; P = .04), tumor subsite (particularly ischiopubic-acetabulum tumors; HR 4.6; P = .02), and increasing volume per 100 mL (HR, 1.2; P = .01) were associated with a higher incidence of local recurrence.CONCLUSIONSCombination surgery and RT is associated with improved local control in patients with pelvic Ewing sarcoma compared with definitive RT. Tumors involving the ischiopubic-acetabulum region and increasing tumor volume at diagnosis are associated with inferior local control. Tumor characteristics did not correlate with choice of local therapy modality suggesting an opportunity to develop best local therapy practices guidelines for future studies based on tumor features.
Author Krailo, Mark
Janeway, Katherine A
Womer, Richard B.
DuBois, Steven G.
Rose, Peter S.
Grier, Holcombe E.
Witten, Brent G.
Gorlick, Richard G.
Harmsen, William S.
Laack, Nadia N.I.
Marcus, Karen J.
Randall, R. Lor
Ahmed, Safia K.
AuthorAffiliation 9 Department of Pediatrics, University of Pennsylvania, Perelman School of Medicine & Children’s Hospital of Philadelphia, Philadelphia, PA, USA
8 Department of Pediatrics, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center & Harvard Medical School, Boston, MA, USA
7 Department of Orthopedic Surgery, UC Davis, Davis, CA, USA
3 Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA
1 Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA
2 Aurora Orthopedics, Milwaukee, MN, USA
5 Department of Preventative Medicine, University of Southern California, Los Angeles, CA, USA
4 Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA
10 Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX, USA
6 Department of Radiation Oncology, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center & Harvard Medical School, Boston, MA, USA
AuthorAffiliation_xml – name: 1 Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA
– name: 9 Department of Pediatrics, University of Pennsylvania, Perelman School of Medicine & Children’s Hospital of Philadelphia, Philadelphia, PA, USA
– name: 10 Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX, USA
– name: 5 Department of Preventative Medicine, University of Southern California, Los Angeles, CA, USA
– name: 7 Department of Orthopedic Surgery, UC Davis, Davis, CA, USA
– name: 2 Aurora Orthopedics, Milwaukee, MN, USA
– name: 4 Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA
– name: 6 Department of Radiation Oncology, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center & Harvard Medical School, Boston, MA, USA
– name: 8 Department of Pediatrics, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center & Harvard Medical School, Boston, MA, USA
– name: 3 Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA
Author_xml – sequence: 1
  givenname: Safia K.
  surname: Ahmed
  fullname: Ahmed, Safia K.
  email: ahmed.safia@mayo.edu
  organization: Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona
– sequence: 2
  givenname: Brent G.
  surname: Witten
  fullname: Witten, Brent G.
  organization: Orthopedic Surgery, Aurora Orthopedics, Milwaukee, Minnesota
– sequence: 3
  givenname: William S.
  surname: Harmsen
  fullname: Harmsen, William S.
  organization: Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota
– sequence: 4
  givenname: Peter S.
  surname: Rose
  fullname: Rose, Peter S.
  organization: Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota
– sequence: 5
  givenname: Mark
  surname: Krailo
  fullname: Krailo, Mark
  organization: Department of Preventative Medicine, University of Southern California, Los Angeles, California
– sequence: 6
  givenname: Karen J.
  surname: Marcus
  fullname: Marcus, Karen J.
  organization: Department of Radiation Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center & Harvard Medical School, Boston, Massachusetts
– sequence: 7
  givenname: R. Lor
  surname: Randall
  fullname: Randall, R. Lor
  organization: Department of Orthopedic Surgery, UC Davis, Davis, California
– sequence: 8
  givenname: Steven G.
  surname: DuBois
  fullname: DuBois, Steven G.
  organization: Department of Pediatrics, Dana-Farber/Boston Children's Cancer and Blood Disorders Center & Harvard Medical School, Boston, Massachusetts
– sequence: 9
  givenname: Katherine A
  surname: Janeway
  fullname: Janeway, Katherine A
  organization: Department of Pediatrics, Dana-Farber/Boston Children's Cancer and Blood Disorders Center & Harvard Medical School, Boston, Massachusetts
– sequence: 10
  givenname: Richard B.
  surname: Womer
  fullname: Womer, Richard B.
  organization: Department of Pediatrics, University of Pennsylvania, Perelman School of Medicine & Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
– sequence: 11
  givenname: Holcombe E.
  surname: Grier
  fullname: Grier, Holcombe E.
  organization: Department of Pediatrics, Dana-Farber/Boston Children's Cancer and Blood Disorders Center & Harvard Medical School, Boston, Massachusetts
– sequence: 12
  givenname: Richard G.
  surname: Gorlick
  fullname: Gorlick, Richard G.
  organization: Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, Texas
– sequence: 13
  givenname: Nadia N.I.
  surname: Laack
  fullname: Laack, Nadia N.I.
  organization: Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36302496$$D View this record in MEDLINE/PubMed
BookMark eNqFkU-PUyEUxYkZ43RGP4KGnW5agfeH91xommY6Y9KkzVijO8KD25aGwhNoTf1mfruh6TjRlQvC4vzOuXDPFbpw3gFCrykZUULr99uR2Qbf9SNGGBsRPqJNSZ6hAW14Oyyq6vsFGpCiJsMi05foKsYtIYRSXr5Al0VdEFa29QD9Hjtpj9FE7Fd45pW0eOJdCt7i-T4pv4OIpdN4Yo0zJ3UR_Nr5mIzCU6mSDxEbd3aaX6DxAuwhazc_jVvjLzLkCIkXMhlwKeJlAJky9c2kDb6X2mTBO7zcQJD98QMe43vofUh4GvwOpw3gycZYHcC9jXjulLd-fcS3we_7l-j5StoIrx7va_R1erOc3A1n89vPk_FsqMqap6FqOemAdQQ6zphsQVclbXTeVtN2QGoOilOmGUApSUGari67FZWQT1Xruiqu0cdzbr_vdqBV_keQVvTB7GQ4Ci-N-FdxZiPW_iDapmirhuSAd48Bwf_YQ0xiZ6ICa6UDv4-C8YIUlDN-QqszqoKPMcDqaQwl4lS72Ipz7eJUuyBcnGrPvjd_v_HJ9afnDHw6A5A3dTAQRFS5EQXaBFBJaG_-M-IB8xnHHA
CitedBy_id crossref_primary_10_1016_j_ijrobp_2023_03_058
crossref_primary_10_3390_cancers15051623
crossref_primary_10_1016_j_radonc_2024_110270
crossref_primary_10_1007_s15004_023_9871_7
crossref_primary_10_1016_j_ijrobp_2023_03_061
Cites_doi 10.1097/CORR.0000000000000962
10.1016/j.ijrobp.2016.04.001
10.1200/JCO.21.00358
10.1002/jso.24081
10.1016/S0360-3016(02)03797-5
10.1200/JCO.2011.41.5703
10.1002/jso.20752
10.1016/j.suronc.2015.11.002
10.1200/JCO.2006.05.9188
10.1056/NEJMoa020890
10.1016/j.ijrobp.2008.02.023
10.1016/j.ijrobp.2017.08.020
10.1016/j.ejca.2012.03.017
10.1016/j.ejca.2016.03.075
10.1016/j.ijrobp.2019.06.504
10.1200/JCO.2008.19.1478
10.1002/pbc.26504
10.1016/j.ejso.2021.05.027
10.1093/annonc/mdm521
10.2106/JBJS.O.00362
10.1016/j.ijrobp.2007.12.014
10.1002/1097-0142(19951015)76:8<1388::AID-CNCR2820760814>3.0.CO;2-F
ContentType Journal Article
Copyright 2022 Elsevier Inc.
Copyright © 2022 Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2022 Elsevier Inc.
– notice: Copyright © 2022 Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1016/j.ijrobp.2022.07.1840
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1879-355X
EndPage 346
ExternalDocumentID 10_1016_j_ijrobp_2022_07_1840
36302496
S0360301622025901
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: U10 CA180899
– fundername: NCI NIH HHS
  grantid: P30 CA015083
– fundername: NCI NIH HHS
  grantid: U10 CA180886
GroupedDBID ---
--K
.1-
.FO
0R~
1B1
1P~
1RT
1~5
4.4
457
4G.
53G
5RE
7-5
AAEDT
AAEDW
AAIAV
AALRI
AAWTL
AAXUO
ABJNI
ABLJU
ABNEU
ABOCM
ABUDA
ACGFS
ACIUM
ADBBV
AENEX
AEVXI
AFCTW
AFRHN
AFTJW
AGZHU
AHHHB
AITUG
AJUYK
ALMA_UNASSIGNED_HOLDINGS
ALXNB
AMRAJ
BELOY
DU5
EBS
EFJIC
F5P
FDB
GBLVA
HED
HMO
IHE
J1W
KOM
LX3
M41
MO0
O9-
OC~
OO-
RNS
ROL
RPZ
SDG
SEL
SES
SSZ
UV1
XH2
Z5R
ZA5
~S-
AFJKZ
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
RIG
.55
.GJ
29J
5VS
AAQFI
AAQQT
AAQXK
AAYXX
ABEFU
ADMUD
ADPAM
ADVLN
AFFNX
AGRDE
ASPBG
AVWKF
AZFZN
CITATION
EJD
FEDTE
FGOYB
FIRID
G-2
HMK
HVGLF
HX~
HZ~
NQ-
R2-
SAE
SEW
UDS
X7M
XPP
ZGI
7X8
5PM
ID FETCH-LOGICAL-c467t-c970be2b0eb722a9ed5418d18489be067ec712d2ee4a0308b64bf1aef1a56d653
ISSN 0360-3016
IngestDate Tue Sep 17 21:30:35 EDT 2024
Fri Oct 25 00:31:41 EDT 2024
Thu Sep 26 18:25:37 EDT 2024
Sat Nov 02 12:22:10 EDT 2024
Fri Feb 23 02:37:05 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License Copyright © 2022 Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c467t-c970be2b0eb722a9ed5418d18489be067ec712d2ee4a0308b64bf1aef1a56d653
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839580
PMID 36302496
PQID 2730317270
PQPubID 23479
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9839580
proquest_miscellaneous_2730317270
crossref_primary_10_1016_j_ijrobp_2022_07_1840
pubmed_primary_36302496
elsevier_sciencedirect_doi_10_1016_j_ijrobp_2022_07_1840
PublicationCentury 2000
PublicationDate 2023-02-01
PublicationDateYYYYMMDD 2023-02-01
PublicationDate_xml – month: 02
  year: 2023
  text: 2023-02-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle International journal of radiation oncology, biology, physics
PublicationTitleAlternate Int J Radiat Oncol Biol Phys
PublicationYear 2023
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Hesla, Tsagozis, Jebsen (bib0009) 2016; 98
Talleur, Navid, Spunt (bib0005) 2016; 96
Indelicato, Keole, Shahlaee (bib0018) 2008; 72
Donati, Yin, Di Bella (bib0015) 2007; 96
Lex, Kurisunkal, Kaneuchi (bib0024) 2021; 47
Gaspar, Rey, Berard (bib0013) 2012; 48
Kneisl, Rosenberg, Anderson (bib0014) 2017
Ng, Jones, Bompadre (bib0022) 2015; 112
Ahmed, Randall, DuBois (bib0001) 2017; 99
Yock, Krailo, Fryer (bib0004) 2006; 24
Andreou, Ranft, Gosheger (bib0002) 2020; 478
Rodriguez-Galindo, Navid, Liu (bib0008) 2008; 19
Granowetter, Womer, Devidas (bib0011) 2009; 27
Leavey, Laack, Krailo (bib0020) 2021; 39
Laskar, Sinha, Chatterjee (bib0006) 2019; 105
Yang, Eckardt, Eilber (bib0023) 1995; 76
Werier, Yao, Caudrelier (bib0017) 2016; 25
Foulon, Brennan, Gaspar (bib0021) 2016; 61
Grier, Krailo, Tarbell (bib0010) 2003; 348
Dirksen, Jurgens, Ranft (bib0019) 2016; 63
Ahmed, Robinson, Arndt (bib0007) 2017; 64
Indelicato, Keole, Shahlaee (bib0016) 2008; 72
Schuck, Ahrens, Paulussen (bib0003) 2003; 55
Womer, West, Krailo (bib0012) 2012; 30
Granowetter (10.1016/j.ijrobp.2022.07.1840_bib0011) 2009; 27
Donati (10.1016/j.ijrobp.2022.07.1840_bib0015) 2007; 96
Kneisl (10.1016/j.ijrobp.2022.07.1840_bib0014) 2017
Andreou (10.1016/j.ijrobp.2022.07.1840_bib0002) 2020; 478
Foulon (10.1016/j.ijrobp.2022.07.1840_bib0021) 2016; 61
Rodriguez-Galindo (10.1016/j.ijrobp.2022.07.1840_bib0008) 2008; 19
Ng (10.1016/j.ijrobp.2022.07.1840_bib0022) 2015; 112
Indelicato (10.1016/j.ijrobp.2022.07.1840_bib0018) 2008; 72
Ahmed (10.1016/j.ijrobp.2022.07.1840_bib0001) 2017; 99
Dirksen (10.1016/j.ijrobp.2022.07.1840_bib0019) 2016; 63
Talleur (10.1016/j.ijrobp.2022.07.1840_bib0005) 2016; 96
Yang (10.1016/j.ijrobp.2022.07.1840_bib0023) 1995; 76
Laskar (10.1016/j.ijrobp.2022.07.1840_bib0006) 2019; 105
Indelicato (10.1016/j.ijrobp.2022.07.1840_bib0016) 2008; 72
Gaspar (10.1016/j.ijrobp.2022.07.1840_bib0013) 2012; 48
Leavey (10.1016/j.ijrobp.2022.07.1840_bib0020) 2021; 39
Womer (10.1016/j.ijrobp.2022.07.1840_bib0012) 2012; 30
Ahmed (10.1016/j.ijrobp.2022.07.1840_bib0007) 2017; 64
Lex (10.1016/j.ijrobp.2022.07.1840_bib0024) 2021; 47
Schuck (10.1016/j.ijrobp.2022.07.1840_bib0003) 2003; 55
Werier (10.1016/j.ijrobp.2022.07.1840_bib0017) 2016; 25
Yock (10.1016/j.ijrobp.2022.07.1840_bib0004) 2006; 24
Grier (10.1016/j.ijrobp.2022.07.1840_bib0010) 2003; 348
Hesla (10.1016/j.ijrobp.2022.07.1840_bib0009) 2016; 98
References_xml – volume: 64
  year: 2017
  ident: bib0007
  article-title: Pelvis Ewing sarcoma: Local control and survival in the modern era
  publication-title: Pediatr Blood Cancer
  contributor:
    fullname: Arndt
– volume: 76
  start-page: 1388
  year: 1995
  end-page: 1397
  ident: bib0023
  article-title: Surgical indications for Ewing's sarcoma of the pelvis
  publication-title: Cancer
  contributor:
    fullname: Eilber
– volume: 98
  start-page: 199
  year: 2016
  end-page: 210
  ident: bib0009
  article-title: Improved prognosis for patients with ewing sarcoma in the sacrum compared with the innominate bones: The Scandinavian Sarcoma Group Experience
  publication-title: J Bone Joint Surg Am
  contributor:
    fullname: Jebsen
– volume: 25
  start-page: 16
  year: 2016
  end-page: 23
  ident: bib0017
  article-title: A systematic review of optimal treatment strategies for localized Ewing's sarcoma of bone after neo-adjuvant chemotherapy
  publication-title: Surg Oncol
  contributor:
    fullname: Caudrelier
– volume: 99
  start-page: 1286
  year: 2017
  end-page: 1294
  ident: bib0001
  article-title: Identification of patients with localized Ewing sarcoma at higher risk for local failure: A Report from the Children's Oncology Group
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: DuBois
– volume: 30
  start-page: 4148
  year: 2012
  end-page: 4154
  ident: bib0012
  article-title: Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: A report from the Children's Oncology Group
  publication-title: J Clin Oncol
  contributor:
    fullname: Krailo
– start-page: 471
  year: 2017
  end-page: 486
  ident: bib0014
  article-title: Bone
  publication-title: AJCC Cancer Staging Manual
  contributor:
    fullname: Anderson
– volume: 19
  start-page: 814
  year: 2008
  end-page: 820
  ident: bib0008
  article-title: Prognostic factors for local and distant control in Ewing sarcoma family of tumors
  publication-title: Ann Oncol
  contributor:
    fullname: Liu
– volume: 48
  start-page: 1376
  year: 2012
  end-page: 1385
  ident: bib0013
  article-title: Risk adapted chemotherapy for localised Ewing's sarcoma of bone: The French EW93 study
  publication-title: Eur J Cancer
  contributor:
    fullname: Berard
– volume: 63
  year: 2016
  ident: bib0019
  article-title: Local control and survival in pelvic Ewing sarcoma (EwS) in the Euro-Ewing99 trial
  publication-title: Pediatr Blood Cancer
  contributor:
    fullname: Ranft
– volume: 24
  start-page: 3838
  year: 2006
  end-page: 3843
  ident: bib0004
  article-title: Local control in pelvic Ewing sarcoma: analysis from INT-0091—A report from the Children's Oncology Group
  publication-title: J Clin Oncol
  contributor:
    fullname: Fryer
– volume: 348
  start-page: 694
  year: 2003
  end-page: 701
  ident: bib0010
  article-title: Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone
  publication-title: New Engl J Med
  contributor:
    fullname: Tarbell
– volume: 105
  start-page: S62
  year: 2019
  ident: bib0006
  article-title: Radiotherapy dose escalation in unresectable Ewing's sarcoma/PNET: Final results of a phase III randomized controlled trial
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Chatterjee
– volume: 72
  start-page: 41
  year: 2008
  end-page: 48
  ident: bib0016
  article-title: Impact of local management on long-term outcomes in Ewing tumors of the pelvis and sacral bones: The University of Florida experience
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Shahlaee
– volume: 112
  start-page: 861
  year: 2015
  end-page: 865
  ident: bib0022
  article-title: The effect of surgery with radiation on pelvic Ewing sarcoma survival
  publication-title: J Surg Oncol
  contributor:
    fullname: Bompadre
– volume: 96
  start-page: 19
  year: 2007
  end-page: 25
  ident: bib0015
  article-title: Local and distant control in non-metastatic pelvic Ewing's sarcoma patients
  publication-title: J Surg Oncol
  contributor:
    fullname: Di Bella
– volume: 55
  start-page: 168
  year: 2003
  end-page: 177
  ident: bib0003
  article-title: Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Paulussen
– volume: 27
  start-page: 2536
  year: 2009
  end-page: 2541
  ident: bib0011
  article-title: Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: A Children's Oncology Group Study
  publication-title: J Clin Oncol
  contributor:
    fullname: Devidas
– volume: 47
  start-page: 2618
  year: 2021
  end-page: 2626
  ident: bib0024
  article-title: Pelvic Ewing sarcoma: Should all patients receive pre-operative radiotherapy, or should it be delivered selectively?
  publication-title: Eur J Surg Oncol
  contributor:
    fullname: Kaneuchi
– volume: 96
  start-page: 119
  year: 2016
  end-page: 126
  ident: bib0005
  article-title: Limited margin radiation therapy for children and young adults with Ewing sarcoma achieves high rates of local tumor control
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Spunt
– volume: 61
  start-page: 128
  year: 2016
  end-page: 136
  ident: bib0021
  article-title: Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G group
  publication-title: Eur J Cancer
  contributor:
    fullname: Gaspar
– volume: 72
  start-page: 871
  year: 2008
  end-page: 877
  ident: bib0018
  article-title: Definitive radiotherapy for ewing tumors of extremities and pelvis: Long-term disease control, limb function, and treatment toxicity
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Shahlaee
– volume: 39
  start-page: 4029
  year: 2021
  end-page: 4038
  ident: bib0020
  article-title: Phase III trial adding vincristine-topotecan-cyclophosphamide to the initial treatment of patients with nonmetastatic Ewing sarcoma: A Children's Oncology Group Report
  publication-title: J Clin Oncol
  contributor:
    fullname: Krailo
– volume: 478
  start-page: 290
  year: 2020
  end-page: 302
  ident: bib0002
  article-title: Which factors are associated with local control and survival of patients with localized pelvic Ewing's sarcoma? A retrospective analysis of data from the Euro-EWING99 trial
  publication-title: Clin Orthop Relat Res
  contributor:
    fullname: Gosheger
– volume: 478
  start-page: 290
  year: 2020
  ident: 10.1016/j.ijrobp.2022.07.1840_bib0002
  article-title: Which factors are associated with local control and survival of patients with localized pelvic Ewing's sarcoma? A retrospective analysis of data from the Euro-EWING99 trial
  publication-title: Clin Orthop Relat Res
  doi: 10.1097/CORR.0000000000000962
  contributor:
    fullname: Andreou
– volume: 96
  start-page: 119
  year: 2016
  ident: 10.1016/j.ijrobp.2022.07.1840_bib0005
  article-title: Limited margin radiation therapy for children and young adults with Ewing sarcoma achieves high rates of local tumor control
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2016.04.001
  contributor:
    fullname: Talleur
– volume: 39
  start-page: 4029
  year: 2021
  ident: 10.1016/j.ijrobp.2022.07.1840_bib0020
  article-title: Phase III trial adding vincristine-topotecan-cyclophosphamide to the initial treatment of patients with nonmetastatic Ewing sarcoma: A Children's Oncology Group Report
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.21.00358
  contributor:
    fullname: Leavey
– volume: 112
  start-page: 861
  year: 2015
  ident: 10.1016/j.ijrobp.2022.07.1840_bib0022
  article-title: The effect of surgery with radiation on pelvic Ewing sarcoma survival
  publication-title: J Surg Oncol
  doi: 10.1002/jso.24081
  contributor:
    fullname: Ng
– volume: 55
  start-page: 168
  year: 2003
  ident: 10.1016/j.ijrobp.2022.07.1840_bib0003
  article-title: Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/S0360-3016(02)03797-5
  contributor:
    fullname: Schuck
– volume: 30
  start-page: 4148
  year: 2012
  ident: 10.1016/j.ijrobp.2022.07.1840_bib0012
  article-title: Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: A report from the Children's Oncology Group
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2011.41.5703
  contributor:
    fullname: Womer
– volume: 96
  start-page: 19
  year: 2007
  ident: 10.1016/j.ijrobp.2022.07.1840_bib0015
  article-title: Local and distant control in non-metastatic pelvic Ewing's sarcoma patients
  publication-title: J Surg Oncol
  doi: 10.1002/jso.20752
  contributor:
    fullname: Donati
– volume: 25
  start-page: 16
  year: 2016
  ident: 10.1016/j.ijrobp.2022.07.1840_bib0017
  article-title: A systematic review of optimal treatment strategies for localized Ewing's sarcoma of bone after neo-adjuvant chemotherapy
  publication-title: Surg Oncol
  doi: 10.1016/j.suronc.2015.11.002
  contributor:
    fullname: Werier
– volume: 24
  start-page: 3838
  year: 2006
  ident: 10.1016/j.ijrobp.2022.07.1840_bib0004
  article-title: Local control in pelvic Ewing sarcoma: analysis from INT-0091—A report from the Children's Oncology Group
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2006.05.9188
  contributor:
    fullname: Yock
– volume: 348
  start-page: 694
  year: 2003
  ident: 10.1016/j.ijrobp.2022.07.1840_bib0010
  article-title: Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone
  publication-title: New Engl J Med
  doi: 10.1056/NEJMoa020890
  contributor:
    fullname: Grier
– volume: 72
  start-page: 871
  year: 2008
  ident: 10.1016/j.ijrobp.2022.07.1840_bib0018
  article-title: Definitive radiotherapy for ewing tumors of extremities and pelvis: Long-term disease control, limb function, and treatment toxicity
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2008.02.023
  contributor:
    fullname: Indelicato
– volume: 63
  year: 2016
  ident: 10.1016/j.ijrobp.2022.07.1840_bib0019
  article-title: Local control and survival in pelvic Ewing sarcoma (EwS) in the Euro-Ewing99 trial
  publication-title: Pediatr Blood Cancer
  contributor:
    fullname: Dirksen
– volume: 99
  start-page: 1286
  year: 2017
  ident: 10.1016/j.ijrobp.2022.07.1840_bib0001
  article-title: Identification of patients with localized Ewing sarcoma at higher risk for local failure: A Report from the Children's Oncology Group
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2017.08.020
  contributor:
    fullname: Ahmed
– volume: 48
  start-page: 1376
  year: 2012
  ident: 10.1016/j.ijrobp.2022.07.1840_bib0013
  article-title: Risk adapted chemotherapy for localised Ewing's sarcoma of bone: The French EW93 study
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2012.03.017
  contributor:
    fullname: Gaspar
– volume: 61
  start-page: 128
  year: 2016
  ident: 10.1016/j.ijrobp.2022.07.1840_bib0021
  article-title: Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G group
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2016.03.075
  contributor:
    fullname: Foulon
– volume: 105
  start-page: S62
  year: 2019
  ident: 10.1016/j.ijrobp.2022.07.1840_bib0006
  article-title: Radiotherapy dose escalation in unresectable Ewing's sarcoma/PNET: Final results of a phase III randomized controlled trial
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2019.06.504
  contributor:
    fullname: Laskar
– volume: 27
  start-page: 2536
  year: 2009
  ident: 10.1016/j.ijrobp.2022.07.1840_bib0011
  article-title: Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: A Children's Oncology Group Study
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2008.19.1478
  contributor:
    fullname: Granowetter
– volume: 64
  year: 2017
  ident: 10.1016/j.ijrobp.2022.07.1840_bib0007
  article-title: Pelvis Ewing sarcoma: Local control and survival in the modern era
  publication-title: Pediatr Blood Cancer
  doi: 10.1002/pbc.26504
  contributor:
    fullname: Ahmed
– volume: 47
  start-page: 2618
  year: 2021
  ident: 10.1016/j.ijrobp.2022.07.1840_bib0024
  article-title: Pelvic Ewing sarcoma: Should all patients receive pre-operative radiotherapy, or should it be delivered selectively?
  publication-title: Eur J Surg Oncol
  doi: 10.1016/j.ejso.2021.05.027
  contributor:
    fullname: Lex
– volume: 19
  start-page: 814
  year: 2008
  ident: 10.1016/j.ijrobp.2022.07.1840_bib0008
  article-title: Prognostic factors for local and distant control in Ewing sarcoma family of tumors
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdm521
  contributor:
    fullname: Rodriguez-Galindo
– volume: 98
  start-page: 199
  year: 2016
  ident: 10.1016/j.ijrobp.2022.07.1840_bib0009
  article-title: Improved prognosis for patients with ewing sarcoma in the sacrum compared with the innominate bones: The Scandinavian Sarcoma Group Experience
  publication-title: J Bone Joint Surg Am
  doi: 10.2106/JBJS.O.00362
  contributor:
    fullname: Hesla
– volume: 72
  start-page: 41
  year: 2008
  ident: 10.1016/j.ijrobp.2022.07.1840_bib0016
  article-title: Impact of local management on long-term outcomes in Ewing tumors of the pelvis and sacral bones: The University of Florida experience
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2007.12.014
  contributor:
    fullname: Indelicato
– start-page: 471
  year: 2017
  ident: 10.1016/j.ijrobp.2022.07.1840_bib0014
  article-title: Bone
  contributor:
    fullname: Kneisl
– volume: 76
  start-page: 1388
  year: 1995
  ident: 10.1016/j.ijrobp.2022.07.1840_bib0023
  article-title: Surgical indications for Ewing's sarcoma of the pelvis
  publication-title: Cancer
  doi: 10.1002/1097-0142(19951015)76:8<1388::AID-CNCR2820760814>3.0.CO;2-F
  contributor:
    fullname: Yang
SSID ssj0001174
Score 2.4809535
Snippet To identify potential clinical prognostic factors associated with a higher risk of local recurrence in patients with localized pelvic Ewing sarcoma treated...
PURPOSETo identify potential clinical prognostic factors associated with a higher risk of local recurrence in patients with localized pelvic Ewing sarcoma...
SourceID pubmedcentral
proquest
crossref
pubmed
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 337
SubjectTerms Bone Neoplasms - pathology
Bone Neoplasms - radiotherapy
Child
Combined Modality Therapy
Humans
Neoplasm Recurrence, Local
Pelvic Neoplasms
Prognosis
Retrospective Studies
Sacrum
Sarcoma, Ewing - pathology
Sarcoma, Ewing - radiotherapy
Title Analysis of Local Control Outcomes and Clinical Prognostic Factors in Localized Pelvic Ewing Sarcoma Patients Treated With Radiation Therapy: A Report From the Children's Oncology Group
URI https://dx.doi.org/10.1016/j.ijrobp.2022.07.1840
https://www.ncbi.nlm.nih.gov/pubmed/36302496
https://search.proquest.com/docview/2730317270
https://pubmed.ncbi.nlm.nih.gov/PMC9839580
Volume 115
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1Za9tAEMcXN4GQl9I77sUUCn0ocq1b6ptrkoamaUJwiN-EVloTmVoKjkwh36yfrK-d2UOSc9DjwcLIK8l4fpqdHc_8xdjbYZAJP09Tywlt38L4Nrd4xD0rFG5oi9iOwhk1Jx9-C_ZPvS9Tf9rr_epULa1qPsiubu0r-R-r4j60K3XJ_oNlm5PiDnyP9sUtWhi3f2XjrqLIV5qUqIFPVp4frWq8oFACzGPT_Xi8rKiujjRa9_RzdopSHVlcYeR5LL6j43i_-0PKdOMtUC1SEvEvZBvchOJLHHVGqdsT0jSQ7EyULoFqcVfxPIbDumllrHvF5d8CR2WmFJ_ahNe8LaRv85IdNYtlc5lKH0xM8LbHRmVmmoXB6HwhdKZ7VqRtDhe_c60c7CcpR_W59bzLhU5C6dRTmww2T52UNcx6t06QOK6pqab5TTn1KIwtjKuma15fdZFqvJ2OD3eVCs2NuUWlOeaDYr6sOEmdOg7pvtISuTsef-6LhQTODVwSZLym9K1iB_3RPbbpoIdE17w5Ojg5O2iCCBtXim3D2Ydbr7rNtsx57oqqbq6arhf_dqKpyQN2Xy-DYKSYfsh6onzEtg51ocdj9tOgDdUMJKCg0QaDNiDaYNCGFm3QaENRQoM2KLRBog0abTBog0YbCG1o0AaN9kcYgQIbCGxAsMGA_e4SDNYgsX7CTvd2J-N9Sz9lxMowSKitLA6HXDh8KHjoOGksct-zoxx_4CjmAoM5kYW2kztCeCmJO_HA4zM7Ffjygzzw3adso6xKscPAtYNg5sReiI7Ry7OY09MocGSKFk657fbZwFgpuVBiMompspwnysIJWTgZhglZuM8iY8tER8Qq0k0Qyj8d-sbYPsEZg_4GTEtRrS4TXLDgTI7rFhzzTLHQfBvDU5-Fa5Q0A0iNfv2TsjiXqvQxLrX8aPj8znO-YNvt7fmSbdTLlXiFEX3NX2v6fwNW5QBc
link.rule.ids 230,315,783,787,888,27936,27937
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Analysis+of+Local+Control+Outcomes+and+Clinical+Prognostic+Factors+in+Localized+Pelvic+Ewing+Sarcoma+Patients+Treated+With+Radiation+Therapy%3A+A+Report+From+the+Children%27s+Oncology+Group&rft.jtitle=International+journal+of+radiation+oncology%2C+biology%2C+physics&rft.au=Ahmed%2C+Safia+K&rft.au=Witten%2C+Brent+G&rft.au=Harmsen%2C+William+S&rft.au=Rose%2C+Peter+S&rft.date=2023-02-01&rft.eissn=1879-355X&rft.volume=115&rft.issue=2&rft.spage=337&rft_id=info:doi/10.1016%2Fj.ijrobp.2022.07.1840&rft_id=info%3Apmid%2F36302496&rft.externalDocID=36302496
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0360-3016&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0360-3016&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0360-3016&client=summon